837 related articles for article (PubMed ID: 16393932)
1. Bispyridinium oximes as antidotal treatment of cyclosarin poisoning-in vitro and in vivo testing.
Bartosova L; Kuca K; Jun D; Kunesova G
Int J Toxicol; 2005; 24(6):399-402. PubMed ID: 16393932
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K; Bajgar J
Clin Toxicol (Phila); 2009 Jan; 47(1):72-6. PubMed ID: 18686075
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K
Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
[TBL] [Abstract][Full Text] [Related]
4. A comparison of tabun-inhibited rat brain acetylcholinesterase reactivation by three oximes (HI-6, obidoxime, and K048) in vivo detected by biochemical and histochemical techniques.
Bajgar J; Hajek P; Zdarova JK; Kassa J; Paseka A; Slizova D; Krs O; Kuca K; Jun D; Fusek J; Capek L
J Enzyme Inhib Med Chem; 2010 Dec; 25(6):790-7. PubMed ID: 21054236
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the reactivating and therapeutic efficacy of two novel bispyridinium oximes (K727, K733) with the oxime HI-6 and obidoxime in sarin-poisoned rats and mice.
Kassa J; Sepsova V; Matouskova L; Horova A; Musilek K
Toxicol Mech Methods; 2015 Mar; 25(3):229-33. PubMed ID: 25894563
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of the reactivating effect of BI-6, a new asymmetrical bispyridinium oxime, with oxime HI-6 and obidoxime on soman-inhibited acetylcholinesterase in the diaphragm and various parts of the brain in rats].
Kassa J; Bajgar J
Cas Lek Cesk; 1999 Aug; 138(17):532-5. PubMed ID: 10566233
[TBL] [Abstract][Full Text] [Related]
7. A comparison of reactivating and therapeutic efficacy of bispyridinium acetylcholinesterase reactivator KR-22934 with the oxime K203 and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
Kassa J; Karasova JZ; Pavlikova R; Musilek K; Kuca K; Bajgar J; Jung YS
Toxicol Mech Methods; 2011 Mar; 21(3):241-5. PubMed ID: 21142778
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods.
Kuca K; Cabal J; Kassa J
Pharmazie; 2004 Oct; 59(10):795-8. PubMed ID: 15544060
[TBL] [Abstract][Full Text] [Related]
9. A comparison of reactivating and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and mice.
Kassa J; Karasova JZ; Caisberger F; Musilek K; Kuca K; Jung YS
J Enzyme Inhib Med Chem; 2010 Aug; 25(4):480-4. PubMed ID: 20233085
[TBL] [Abstract][Full Text] [Related]
10. The evaluation of neuroprotective efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats.
Kassa J; Karasova J; Vasina L
J Appl Toxicol; 2007; 27(6):621-30. PubMed ID: 17685413
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the neuroprotective efficacy of newly developed oximes (K206, K269) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats.
Kassa J; Karasova JZ; Bajgar J; Tesarova S; Kuca K; Musilek K
Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):228-35. PubMed ID: 19143747
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the potency of a novel bispyridinium oxime K203 and currently available oximes (obidoxime, HI-6) to counteract the acute neurotoxicity of sarin in rats.
Kassa J; Misik J; Karasova JZ
Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):333-8. PubMed ID: 22536919
[TBL] [Abstract][Full Text] [Related]
13. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of tabun poisoning in rats and mice.
Kassa J; Karasova JZ; Pavlikova R; Misik J; Caisberger F; Bajgar J
J Appl Toxicol; 2010 Mar; 30(2):120-4. PubMed ID: 19746406
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, trimedoxime, HI-6) to counteract acute toxic effects of tabun and cyclosarin in mice.
Kassa J; Humlicek V
Drug Chem Toxicol; 2008; 31(1):127-35. PubMed ID: 18161512
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the potency of the oxime HLö-7 and currently used oximes (HI-6, pralidoxime, obidoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods.
Kuca K; Cabal J; Kassa J; Jun D; Hrabinová M
Acta Medica (Hradec Kralove); 2005; 48(2):81-6. PubMed ID: 16259317
[TBL] [Abstract][Full Text] [Related]
16. In vitro reactivation potency of some acetylcholinesterase reactivators against sarin- and cyclosarin-induced inhibitions.
Kuca K; Cabal J; Jun D; Kassa J; Bartosová L; Kunesová G
J Appl Toxicol; 2005; 25(4):296-300. PubMed ID: 16025528
[TBL] [Abstract][Full Text] [Related]
17. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-and tabun-poisoned rats.
Kassa J; Jun D; Kuca K
J Enzyme Inhib Med Chem; 2007 Jun; 22(3):297-300. PubMed ID: 17674811
[TBL] [Abstract][Full Text] [Related]
18. Current understanding of the application of pyridinium oximes as cholinesterase reactivators in treatment of organophosphate poisoning.
Jokanović M; Stojiljković MP
Eur J Pharmacol; 2006 Dec; 553(1-3):10-7. PubMed ID: 17109842
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the potency of newly developed oximes (K027, K048) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
Kassa J; Kunesova G
J Appl Toxicol; 2006; 26(4):309-16. PubMed ID: 16552727
[TBL] [Abstract][Full Text] [Related]
20. In vitro potency of H oximes (HI-6, HLö-7), the oxime BI-6, and currently used oximes (pralidoxime, obidoxime, trimedoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase.
Kuca K; Cabal J; Kassa J; Jun D; Hrabinova M
J Toxicol Environ Health A; 2006 Aug; 69(15):1431-40. PubMed ID: 16766478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
